Zidovudine
- Product NDC
- 70518-1656
- 11-digit product format
- 705181656
- Labeler code
- 70518
- Product ID
- 70518-1656_e5be75b9-323a-4cd7-e053-2a95a90a8f15
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Zidovudine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090092
- Marketing category
- ANDA
- Marketing start
- 2018-11-08
- Marketing end
- 0000-00-00
- Substance
- ZIDOVUDINE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1656-0 | 70518165600 | 30 TABLET in 1 BLISTER PACK (70518-1656-0) | 30 tablet | 2018-11-08 | 0000-00-00 | No | No | Current |